AGM Proceedings:
Points from the doc:
-
Order Book:
Sales for FY 24 was Rs 80 cr and the order book is Rs 130 cr (as of Sep 24)
-
FPO Capex:
Comany mentioned to have their Trial run in September 2024 in their FPO RHP and it is in line.
Considering these two points, along with some proceeds for WC from FPO, company has very high chance of reporting a considerable top line growth in FY 25. While the pre-covid and post-covid OPM margins were in the range of 8-10%, the margins keep on fluctuating.
Do consider the historic valuations and dilution by FPO.
Disc: Not Invested.
Source: OMFURN_21092024191252_OmfurnProceedingsAGM21092024.pdf (nseindia.com)
| Subscribe To Our Free Newsletter |
